CClinicalTrials.gg
Status unknownNCT05736510BB_emergenceUpdated Feb 21, 2023

Brainwave Entrainment During Emergence

An interventional study of Binaural sound and Control in Anesthesia, General, sponsored by Seoul National University Hospital. Status unknown at 1 site in Korea, Republic of. Open to female participants aged 19 Years to 50 Years. Per ClinicalTrials.gov, last updated 2023-02-21.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Feb 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Randomized
Ages
19 Years to 50 Years
Sex
Female
01

Study summary

The investigators will compare whether there is a significant difference in the time required for general anesthesia recovery according to application of the binaural sound after surgery.

Read the detailed description

After entering the operating room, electrocardiogram, pulse oxygen saturation, blood pressure meter, and sedline are attached to start monitoring vital signs and patient state index (PSI). propofol and the remifentanil continuous infusion device is connected as close as possible to the catheter insertion site. Anesthesia is induced with total intravenous anesthesia (4 ng/mL of Remifentanil, 4 mg/mL of propofol). Rocuronium is administered after checking the patient's unconsciousness. When appropriate neuromuscular blocking is reached, tracheal intubation is performed. The anesthesia maintenance is performed to keep stable vital sign and PSI between 25 and 50. End-tidal carbon dioxide is controlled to be between 30 mmHg and 40 mmHg.

When the pneumoperitoneum ends, the propofol concentration is recorded (T0). The anesthesiologist in charge of anesthesia puts headphones on the patient and plays the allocated file. The allocated file is named the screening number. Depending on the allocated group, the audio file is binaural sound for the experimental group, and a silent file for the control group.

The anesthesiologist cannot know group allocation, since the length and size of files are the same. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and record the time (T1). At the same time, the investigators reverse neuromuscular blocking using sugammadex (2mg/ kg).

When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.

Record the time (T2) when the PSI reaches 50, the time when the patient opens eyes (T3), and the time (T4) when the extubation of endotracheal tube was done. T3-T1 is the time it took the patient to open his eyes (primary end point). Write the effect site concentration of propofol and remifentanil recorded for each time points.

The patient's sedline EEG data from the end of pneumoperitoneum until the patient's exit operating room is collected as raw data. The patient's blood pressure and heart rate are measured at each time points. The investigators evaluate sedation and agitation of the patients using Ramsay Sedation Scale.

In the post-anesthesia care unit, pain score (NRS 0-10), postoperative nausea vomiting, medication, and length of stay are investigated.

02

Conditions studied

  • Anesthesia, General

Keywords

  • Brain Waves
  • anesthesia
03

In context

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Patients between 19 and 50 years of age who are scheduled to undergo laparoscopic salpingo-oophorectomy/ ovarian cystectomy
  • Intellectual level to understand the procedures of the clinical trial
  • Physical status classification of the American Society of Anesthesiology (ASA) 1-2 grades

Exclusion criteria

Exclusion Criteria:

  • Patients with hearing loss or using hearing aids
  • Patients who have been given narcotic painkillers or sedative drugs within a week.
  • Alcohol-dependent or drug-dependent patients
  • Patients with drug hypersensitivity to anesthetics
  • Patients with arrhythmia, cardiovascular disease, impaired heart function, decreased circulatory blood flow
  • Patients with liver failure
  • Patients with other major medical or psychological disorder that will affect the treatment response
  • Patients with claustrophobia or anxiety disorder
  • Patients with organic brain disorders or other conditions that cannot be properly measured by PSI
  • Patients who have been newly diagnosed with myocardial infarction, cerebral ischemic seizure, stroke, clinically significant coronary artery disease, or have undergone percutaneous carotid coronary dilatation or coronary bypass treatment within 6 months
  • Patients with a history of epilepsy or seizures
  • Patients with acute angle glaucoma
  • Patients who deemed unsuitable for this clinical trial
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
106 participants (estimated)

Study arms

  • Experimental
    Binaural

    Exposed to binaural sound (40 Hz) from the end of pneumoperitoneum until the eyes are open

    Other: Binaural sound

  • Active comparator
    Control

    Applied silent files from the end of pneumoperitoneum until the eyes are open

    Other: Control

Interventions

  • OtherBinaural sound

    When the pneumoperitoneum ends, the anesthesiologist puts headphones on the patient and plays the allocated file. In the experimental group, the allocated file is binaural sound with 40Hz beat. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and, we reverse neuromuscular blocking using sugammadex (2mg/ kg). When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.

  • OtherControl

    When the pneumoperitoneum ends, the anesthesiologist puts headphones on the patient and plays the allocated file. In the control group, the allocated file is silent. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and, we reverse neuromuscular blocking using sugammadex (2mg/ kg). When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.

06

What researchers measure

Primary outcomes

  1. Eye opening time

    The time it takes to open patient's eyes in response to the voice after the anesthetic infusion is terminated.

    Time frame: after the anesthetic infusion is terminated until 1 hour

Secondary outcomes

  1. Extubation time

    The time it takes from the end of the anesthetic infusion to the extubation of endotracheal tube

    Time frame: after the anesthetic infusion is terminated until 1 hour

  2. Systolic blood pressure

    Noninvasive systolic blood pressure

    Time frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour

  3. Diastolic blood pressure

    Noninvasive diastolic blood pressure

    Time frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour

  4. Mean blood pressure

    Noninvasive mean blood pressure

    Time frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour

  5. Heart rate

    Heart rate

    Time frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour

  6. alpha band activity

    alpha band activity of electroencephalogram from Sedline data

    Time frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour

  7. beta band activity

    beta band activity of electroencephalogram from Sedline data

    Time frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour

  8. theta band activity

    theta band activity of electroencephalogram from Sedline data

    Time frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour

  9. delta band activity

    delta band activity of electroencephalogram from Sedline data

    Time frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour

  10. Ramsay Sedation Scale

    The degree of patient's sedation or agitation (1 to 6: 1 means "Patient is anxious and agitated or restless, or both"; 6 means "Patient exhibits no response")

    Time frame: When the end of anesthesia within 5minutes

  11. Postoperative recovery score

    Postoperative recovery score (0-10; activity (0-2), respiration (0-2), circulation (0-2), consciousness level (0-2), and color (0-2); optimum score 10)

    Time frame: When the patient stay in post-anesthesia care unit up to 1 hour

  12. Pain score

    Postoperative pain score using numeric rating scale(0-10: 0, no pain; 10, worst possible pain)

    Time frame: When the patient stay in post-anesthesia care unit up to 1 hour

  13. Rate of postoperative nausea and vomiting

    Rate of postoperative nausea and vomiting

    Time frame: When the patient stay in post-anesthesia care unit up to 1 hour

  14. Length of stay in post-anesthesia care unit

    Length of stay in post-anesthesia care unit

    Time frame: From entering to exit the post-anesthesia care unit up to 2 hours

  15. Medication

    Rate of administration of any medication in post-anesthesia care unit

    Time frame: When the patient stay in post-anesthesia care unit up to 1 hour

07

Study locations

1 site
  • Seoul National University Hospital
    Seoul, Korea, Republic of
08

References and documents

Publications

  • Schmid W, Marhofer P, Opfermann P, Zadrazil M, Kimberger O, Triffterer L, Marhofer D, Klug W. Brainwave entrainment to minimise sedative drug doses in paediatric surgery: a randomised controlled trial. Br J Anaesth. 2020 Sep;125(3):330-335. doi: 10.1016/j.bja.2020.05.050. Epub 2020 Jul 8. PubMed 32653082 ↗
  • Ozkose Z, Yalcin Cok O, Tuncer B, Tufekcioglu S, Yardim S. Comparison of hemodynamics, recovery profile, and early postoperative pain control and costs of remifentanil versus alfentanil-based total intravenous anesthesia (TIVA). J Clin Anesth. 2002 May;14(3):161-8. doi: 10.1016/s0952-8180(01)00368-3. PubMed 12031745 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05736510
Lead sponsor
Seoul National University Hospital
Responsible party
Jeong-Hwa Seo (Professor, Seoul National University Hospital) — Principal investigator
First posted
Feb 21, 2023
Start date
Feb 15, 2023 (estimated)
Primary completion
Nov 15, 2023 (estimated)
Completion
Feb 23, 2024 (estimated)
Last update
Feb 21, 2023

Study contacts

Jeong-Hwa Seo, MD.,PhD.
Contact
eongpa@empas.com
+82-10-55020551
Jeong-Hwa Seo, MD.,PhD.
principal investigator · Seoul National University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion